Company Filing History:
Years Active: 2021-2025
Title: Annelies Roobrouck: Innovator in T Cell Recruiting Polypeptides
Introduction
Annelies Roobrouck is a prominent inventor based in Oudenaarde, Belgium. She has made significant contributions to the field of immunology, particularly in the development of T cell recruiting polypeptides. With a total of four patents to her name, her work is paving the way for innovative cancer treatments.
Latest Patents
Annelies Roobrouck's latest patents include groundbreaking advancements in T cell recruiting polypeptides. One of her notable inventions involves polypeptides that bind CD3 on T cells, which can be utilized in methods for treating various cancers. Another significant patent features polypeptides capable of binding CD123 on target cells and the constant domain of TCR on T cells. These polypeptides have potential applications in treating CD123 associated cancers and inflammatory conditions.
Career Highlights
Annelies Roobrouck is currently associated with Ablynx N.V., where she continues to innovate in the field of biopharmaceuticals. Her work is characterized by a strong focus on developing therapies that harness the immune system to combat diseases.
Collaborations
Annelies collaborates with talented professionals in her field, including Diane Van Hoorick and João Vieira. These partnerships enhance her research and contribute to the advancement of her projects.
Conclusion
Annelies Roobrouck is a remarkable inventor whose work in T cell recruiting polypeptides is making a significant impact in cancer treatment. Her innovative spirit and dedication to research continue to inspire advancements in immunotherapy.